Discover
Screen a defined universe using technical, liquidity and relative-strength factors. A qualifying signal starts investigation; it is not a buy order.
A deliberate approach to market research. See the evidence, scrutinise the assumptions and understand what changed—without the noise of trading tips.
Dated research, not personalised investment advice. No brokerage orders or money management.
Use the educational SIGNAL evidence lab with source-dated ECB exchange-rate reference series, five-session change and longer-window factors when sufficient observations exist. Or analyse your own data entirely in your browser.
The full stock research platform remains separate; commercial equity-data licensing, authentication and regulatory reviews are ongoing. ECB statistics are obtainable free from the ECB.
Explore the full ten-department research architecture. The public preview links to official sources and explains how each function works. Detailed private research and unlicensed market data are kept separate from public use.
The approach is closer to a research journal than a traditional stock-tipping site. Every finding should be attributable to observations and open to challenge.
Screen a defined universe using technical, liquidity and relative-strength factors. A qualifying signal starts investigation; it is not a buy order.
Combine independent market agents, issuer disclosures, macro observations and licensed analyst opinions where available.
Compare hypotheses with historical results and preserve losing observations. Forward-only paper records matter more than backtest claims.
Many platforms offer stock headlines, watchlists or scores. Baker Research is built around a more specific idea: show how an investment hypothesis was formed, what independent evidence supports it, what conflicts with it and how it subsequently performed. It isn't a claim that our returns beat competing services.
Our defined 85-stock SIGNAL universe uses a documented technical, liquidity and relative-strength framework. Its scoring criteria are transparent; qualification triggers investigation, not a trade instruction.
Independent monitoring of market conditions, corporate filings and risk flags provides broader context. When agents or sources cannot verify something, the research says so.
Historical reconstructions are labelled as hindsight tests, while future paper decisions can be dated and judged against later evidence. Results include costs, limitations and drawdowns.
Research outputs identify observation dates, missing inputs and conflicts. Third-party analyst Buy/Hold/Sell distributions appear only with commercial data permission and attribution.
Screening, agent findings, risk checks and strategy comparisons live together in a carefully designed daily workflow, instead of requiring you to piece together several disconnected reports.
30 days free for eligible new members, then a clearly disclosed monthly subscription. Designed for a modest research budget—not the price of an institutional terminal.
See transparent membership terms →Research availability depends on the source and its commercial licence. No investment profits, superior returns, analyst feeds or financial advice are promised.
The proposed £4.99 educational membership includes ten original evidence-driven research workbooks, structured due-diligence templates and links to primary sources. The free SIGNAL Lab remains available to everyone. Licensed stock-price and issuer-specific research feeds are not included in this initial paid offer.
£0 due during the first 30 days for eligible new members. From day 31 the subscription renews at £4.99 per month unless cancelled beforehand.
Advance trial reminders and online cancellation will be verified before subscriptions are available. No live customer payments are accepted yet.
Member access & trial detailsPrelaunch offer: the paid workbooks are not yet available for signup. The free SIGNAL Lab and Research Desk previews are already live.
Account access uses a one-time email link. Payment details, if billing is enabled after launch, are collected securely by Stripe—not by this research site.
Before live launch, the £4.99 subscription remains a test-mode offer. This website is not an FCA-authorised investment service.
Sign in with an active membership to access the research terminal. This content is protected on the server, not by a browser-only paywall.
Loading dated research…
For organisational memberships, commercial partnerships and business sales enquiries, please get in touch.
Email cbaker@bakerenterprisescom.com
Charles Harry James Baker trading as Baker Research. Full business details and support information.
We welcome feedback. Tell us what research you would find useful, flag an inaccurate source or suggest an improvement. Write to cbaker@bakerenterprisescom.com. Do not send passwords, card details or sensitive financial information.
Research should earn trust through its evidence and through how it treats customer information. Baker Research is designed around separate services for sign-in, payment processing and research access.
Our planned passwordless accounts use Supabase authentication. Member identity is checked by the server before access to subscription-only research.
When activated, subscription checkout and cancellation use Stripe-hosted pages. Baker Research does not collect or store card numbers on this website.
Member billing records are designed for private database access, and the subscriber-facing platform is separate from private investment accounts or personal portfolios.
Security controls reduce risk; no online service can promise absolute security. Membership sign-in, live billing and commercial data publication remain disabled until setup and operational checks have been completed.
Research observations, screens, historical simulations and third-party analyst distributions are not financial advice or personal recommendations to buy, sell or hold any security. Financial markets involve the risk of loss, and there is no guarantee that a historical strategy will be profitable in the future.
Company and market data can be delayed, corrected or incomplete. Analyst ratings will only appear where commercial distribution rights and source attribution have been verified. The service is not an investment adviser, broker, regulated hedge fund or custodian.
The operator's business identity and current service disclosures are available through our contact information, privacy notice and proposed membership terms. Final consumer terms, market-data permissions and regulatory review remain outstanding before accepting subscriptions.